Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

1(20%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_2

20%

Ph phase_3

20%

Ph not_applicable

40%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

1(25.0%)

Phase 3Large-scale testing

1(25.0%)

N/ANon-phased studies

2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

25.0%

1 of 4 finished

Non-Completion Rate

75.0%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Terminated(3)

Detailed Status

Withdrawn3

Active, not recruiting1

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 21 (25.0%)

Phase 31 (25.0%)

N/A2 (50.0%)

Trials by Status

active_not_recruiting120%

completed120%

withdrawn360%

Recent Activity

1 active trials

Showing 5 of 5

active_not_recruiting

Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98

NCT00369850

Clinical Trials (5)

Showing 5 of 5 trials

NCT03971955

CharacterIzation of Adult Onset Autoimmune Diabetes

Active Not Recruiting

NCT00287430Not Applicable

Growth Hormone Use in Adolescents and Adults With Cystic Fibrosis

Withdrawn

NCT00286676Phase 2

The Use of Nutropin Depot in HIV-infected Adult Males

Withdrawn

NCT00287443Not Applicable

Metabolic Abnormalities in Hispanic Children With Cystic Fibrosis

Withdrawn

NCT00369850Phase 3

Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98

Completed

All 5 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 5